Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Rexulti® (brexpiprazole) – New indication
May 11, 2023 - The FDA announced the approval of Otsuka and Lundbeck’s Rexulti (brexpiprazole), for treatment of agitation associated with dementia due to Alzheimer’s disease.
